Objective: In the search for the optimal treatment of advanced cervica
l cancer, the identification of valid prognostic factors obtainable wi
thout histopathologic investigation of the entire tumor and the locore
gional lymph nodes is of paramount interest. Tumor microvessel density
has recently been demonstrated to correlate strongly with disease agg
ressiveness in breast cancer and other malignancies. Methods: We estab
lished a computerized image analysis system to quantify tumor microvas
cularity by using the closest-individual method, which determines the
distribution of distances from random points within the tumor to the c
losest microvessel (DTCMV). Tumor microvascularity was assessed in par
affin sections of two cylindrical 2 x 20-mm core biopsies obtained tra
nsvaginally from the 12 and 6 o'clock positions of each tumor and then
immunohistochemically stained for Factor VIII-related antigen. The on
cologic relevance of tumor vascularity is studied in an open prospecti
ve trial. Results: Tumor vascularity was quantified in 42 patients wit
h cervical cancers >3 cm in largest diameter, FIGO stages Ib-IVa. This
new parameter representing pathophysiological tumor-host interactions
was independent of various other patient and tumor characteristics, i
ncluding age, FIGO stage, tumor size, differentiation, lymph node meta
stases and lymphatic space involvement. Thirty-nine patients were trea
ted with curative intent either by primary surgery (n = 22) or radiati
on (n = 17), After a median observation time of 18 months (range 4-41
months), the patients with higher tumor vascularity (mean DTCMV <83 mu
m) had significantly shorter disease-free (P = 0.025) and overall (P
= 0.032) survival probabilities than patients with lower tumor vascula
rity (mean DTCMV greater than or equal to 83 mu m). Cox regression ana
lysis identified tumor vascularity as the strongest independent progno
stic factor in this group of patients. Conclusions: The assessment of
tumor microvascularity by computerized image analysis of defined tumor
biopsies could become a novel means of predicting tumor aggressivenes
s in non-early cervical cancer. (C) 1995 Academic Press, Inc.